Skip to content
PeptideWiki.bio

Metabolic

Oxyntomodulin

Also called OXM, Glucagon(1-37)

InjectableEvidence BTwice a day
Half-life
0.2hours
Typical vial
5 / 10mg
Research amounts
1–2mg

per administration

Common schedule
Twice a day
Some human use

It has been used in people, but no trial has settled how much or how often.

Quick start

Oxyntomodulin at a glance — the figures, plus how it's commonly run. Reference only, not medical advice.

Typical dose
1–2 mg per administration
How often
Twice a day
Where
Subcutaneous — abdomen, thigh, or upper arm Sites and rotation
Time to steady level
~1 hours — about five half-lives
Storage
Dry vial kept cold and dark; a mixed vial in the fridge at 2–8 °C. Details

A research and community reference, not medical advice. Figures are descriptive, vary between sources, and are not a recommendation for use.

Work out your draw

These numbers are a starting point — change any of them.

Vial label

Copy this into your label printer.

Published research contexts for Oxyntomodulin describe 12 mg per administration. Descriptive only, not a recommendation.

Roughly 12 minutes in plasma; cleared quickly, so the curve is a series of spikes.

A GLP-1 and glucagon receptor dual-acting gut peptide studied for weight reduction in small academic research. The reported schedule was about 400 nmol/kg subcutaneously three times daily before meals (Wynne 2005); it is not established for general use, and the calculator's default of twice daily is the closest available spacing, so no schedule table is shown.

Modelled level — twice a day

1× is the peak after a single dose.

Steady-state peak
0.98× single dose

Read off the modelled curve, not an even-interval formula

Time to steady state
1hours

About five half-lives

Administrations
14/ week

Where these numbers come from

  • Wynne K et al., Diabetes 2005;54:2390Small controlled study of pre-meal subcutaneous oxyntomodulin at about 400 nmol/kg three times daily, with weight reduction over four weeks.

Next steps